Genmab | GEN - Interest Income



Genmab reported DKK25M in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
Almirall 2M 1.44M Mar/2025
Amarin USD 3.37M 3.37M Dec/2024
argenx SE 38.4M 1.28M Jun/2025
AstraZeneca 68M 16M Jun/2025
Bayer 92M 22M Mar/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Exelixis USD 16.79M 2.29M Jun/2025
Fresenius Medical Care EUR 21.85M 6.87M Jun/2025
Galapagos EUR 12.56M 4.66M Mar/2025
Genmab DKK 25M 8M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
GRIFOLS 9.56M 4.5M Jun/2025
Hikma Pharmaceutical 4M 0 Dec/2024
Insmed 0 0 Mar/2025
Merck 17M 11M Jun/2025
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025